Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3767440010 | Dihydroergotamine-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3767441014 | Product containing dihydroergotamine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dihydroergotamine-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in parenteral dose form | Is a | Product containing dihydroergotamine (medicinal product) | true | Inferred relationship | Some | ||
| Dihydroergotamine-containing product in parenteral dose form | Has active ingredient | Dihydroergotamine (substance) | true | Inferred relationship | Some | 1 | |
| Dihydroergotamine-containing product in parenteral dose form | Plays role | Antimigraine therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dihydroergotamine only product in parenteral dose form | Is a | True | Dihydroergotamine-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR